Pacira | PCRX - Ricavi Di Vendita

Prezzo Delle Azioni
23.26
Cambio Giornaliero
-0.27 -1.15%
Mensile
2.29%
Annuale
1.71%
Q1 Previsione
21.34




I Saldi Cambiamento Data
Assertio Holdings USD 29.2M 1.92M 2024-09
Astellas Pharma JPY 571.21B 46.89B 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 7.6M 46.54M 2025-03
Heron Therapeutics USD 32.81M 3.21M 2024-09
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
J&J USD 24.6B 610M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Novo Nordisk DKK 79.14B 4.16B 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09
Xoma USD 25K 5M 2024-09
Zoetis USD 2.4B 0 2025-12